With its Vivalytic analysis platform, Bosch has set itself the goal of making fast and highly precise diagnostics accessible at the point of care. To achieve this, Bosch has now agreed on a strategic partnership with Randox Laboratories Ltd.

AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies.

Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024.

Innovative Hi-C-like technique shows enhanced sensitivity for detecting structural variants and chromatin topology features in cancer.

Enhanced performance and 33% energy savings support quality and sustainability goals in the laboratory.

Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCR™ technology for molecular residual disease monitoring of patients across a range of solid tumor types.

Sterilis Solutions and Polycarbin proudly announce their strategic partnership aimed at enhancing sustainability in laboratory waste management.

First commercial source of on-demand GMP CD34+ hematopoietic stem cells for clinical manufacturing in the industry. OrganaBio leveraging years of in-house tissue sourcing and cell isolation experience to produce high-quality GMP-compliant cells.

HORIBA Instruments Inc., is proud to announce the launch of their dedicated product solutions to address the impacts of microplastics on the environment and life forms.

Revolutionary genomic research applied an innovative use of multiomics and biomimetic digital twins to unveil new DNA variants associated with the development of endometrial related disorders.